Free Newsletter
AIDS scientist backed on new vaccine approach
The famed AIDS scientist Dr. Robert Gallo of the University of Maryland's Institute of Human Virology has won a $15 million grant from the Bill & Melinda Gates Foundation to pursue his work on an AIDS vaccine. In animal studies, the experimental vaccine has created antibodies that work against various strains of HIV. The vaccine is designed to defeat the virus's ability to constantly mutate. Baltimore-based Profectus BioSciences--a spin-off of the institute--undertook the animal studies of the vaccine. The Gates Foundation is a major contributor in this field, providing $287 million in grants to 19 AIDS vaccine researchers around the globe.
- see this Baltimore Sun report
Related Articles:
Gates Foundation restructures, refocuses. Report
Gates adds $287M to HIV vaccine research. Report
Gates Foundation readies $258M for new malaria programs. Report
Comments
$287 million in grants is a bit of a joke. since they have 30 to 60 billion in tax sheltered money for the HIV vaccine.
Where is the IRS when you need them.
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: